RT @doctorneyro: Long-term #treatment with #denosumab decreases upper #limbfracture #risk and increases #forearm #BMD (#bonemineraldensity)…
RT @doctorneyro: Long-term #treatment with #denosumab decreases upper #limbfracture #risk and increases #forearm #BMD (#bonemineraldensity)…
RT @doctorneyro: Long-term #treatment with #denosumab decreases upper #limbfracture #risk and increases #forearm #BMD (#bonemineraldensity)…
RT @doctorneyro: Long-term #treatment with #denosumab decreases upper #limbfracture #risk and increases #forearm #BMD (#bonemineraldensity)…
Long-term #treatment with #denosumab decreases upper #limbfracture #risk and increases #forearm #BMD (#bonemineraldensity), suggesting beneficial effects on both #cortical and #trabecularbone accruing over time on #osteoporosis. https://t.co/PIxs9b0GTf htt
RT @Osteoporosis_NL: Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analys…
Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group. Bilezikian JP et al. Osteoporos Int. 2019 Jun 14 https://t.co/U2zacYvs4Q https://t.co/FWU